APO RESEARCH · REPORT
Zika Virus Testing
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Product & engineering
Understand the product.
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Selected research
Industry Research
Zika Virus Testing Industry Research Report 2026
Market perspective
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Global Zika Virus Testing key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs, etc.
Report Scope
Read the full market overview
This report quantifies the global Zika Virus Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Zika Virus Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Zika Virus Testing Market by Company
Chembio
Quest Diagnostics
ARUP Laboratories
Luminex
Simens
Abbott Molecular
Hologic
ELITech Molecular Diagnostics
EUROIMMUN US
Creative Diagnostics
Vela Diagnostics
InBios International
Primerdesign
Altona Diagnostics
Zika Virus Testing Segment by Type
Molecular Test
Serologic Test
Zika Virus Testing Segment by Application
Diagnostic Centers
Hospitals
Pathology Labs
Zika Virus Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Zika Virus Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Zika Virus Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Molecular Test
- Serologic Test
Applications
- Diagnostic Centers
- Hospitals
- Pathology Labs
Companies covered
- Chembio
- Quest Diagnostics
- ARUP Laboratories
- Luminex
- Simens
- Abbott Molecular
- Hologic
- ELITech Molecular Diagnostics
- EUROIMMUN US
- Creative Diagnostics
- Vela Diagnostics
- InBios International
- Primerdesign
- Altona Diagnostics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Zika Virus Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Molecular Test
- 2.2.3 Serologic Test
- 2.3 Zika Virus Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diagnostic Centers
- 2.3.3 Hospitals
- 2.3.4 Pathology Labs
- 2.4 Assumptions and Limitations
3 Zika Virus Testing Breakdown Data by Type
- 3.1 Global Zika Virus Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Zika Virus Testing Forecasted Market Size by Type (2027-2032)
4 Zika Virus Testing Breakdown Data by Application
- 4.1 Global Zika Virus Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Zika Virus Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Zika Virus Testing Market Perspective (2021-2032)
- 5.2 Global Zika Virus Testing Growth Trends by Region
- 5.2.1 Global Zika Virus Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Zika Virus Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Zika Virus Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Zika Virus Testing Market Dynamics
- 5.3.1 Zika Virus Testing Industry Trends
- 5.3.2 Zika Virus Testing Market Drivers
- 5.3.3 Zika Virus Testing Market Challenges
- 5.3.4 Zika Virus Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Zika Virus Testing Players by Revenue
- 6.1.1 Global Top Zika Virus Testing Players by Revenue (2021-2026)
- 6.1.2 Global Zika Virus Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Zika Virus Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Zika Virus Testing Head Office and Area Served
- 6.4 Global Zika Virus Testing Players, Product Type & Application
- 6.5 Global Zika Virus Testing Manufacturers Established Date
- 6.6 Global Zika Virus Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Zika Virus Testing Market Size (2021-2032)
- 7.2 North America Zika Virus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Zika Virus Testing Market Size by Country (2021-2026)
- 7.4 North America Zika Virus Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Zika Virus Testing Market Size (2021-2032)
- 8.2 Europe Zika Virus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Zika Virus Testing Market Size by Country (2021-2026)
- 8.4 Europe Zika Virus Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Zika Virus Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Zika Virus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Zika Virus Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Zika Virus Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Zika Virus Testing Market Size (2021-2032)
- 10.2 South America Zika Virus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Zika Virus Testing Market Size by Country (2021-2026)
- 10.4 South America Zika Virus Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Zika Virus Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Zika Virus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Zika Virus Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Zika Virus Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Chembio
- 12.1.1 Chembio Company Information
- 12.1.2 Chembio Business Overview
- 12.1.3 Chembio Revenue in Zika Virus Testing Business (2021-2026)
- 12.1.4 Chembio Zika Virus Testing Product Portfolio
- 12.1.5 Chembio Recent Developments
- 12.2 Quest Diagnostics
- 12.2.1 Quest Diagnostics Company Information
- 12.2.2 Quest Diagnostics Business Overview
- 12.2.3 Quest Diagnostics Revenue in Zika Virus Testing Business (2021-2026)
- 12.2.4 Quest Diagnostics Zika Virus Testing Product Portfolio
- 12.2.5 Quest Diagnostics Recent Developments
- 12.3 ARUP Laboratories
- 12.3.1 ARUP Laboratories Company Information
- 12.3.2 ARUP Laboratories Business Overview
- 12.3.3 ARUP Laboratories Revenue in Zika Virus Testing Business (2021-2026)
- 12.3.4 ARUP Laboratories Zika Virus Testing Product Portfolio
- 12.3.5 ARUP Laboratories Recent Developments
- 12.4 Luminex
- 12.4.1 Luminex Company Information
- 12.4.2 Luminex Business Overview
- 12.4.3 Luminex Revenue in Zika Virus Testing Business (2021-2026)
- 12.4.4 Luminex Zika Virus Testing Product Portfolio
- 12.4.5 Luminex Recent Developments
- 12.5 Simens
- 12.5.1 Simens Company Information
- 12.5.2 Simens Business Overview
- 12.5.3 Simens Revenue in Zika Virus Testing Business (2021-2026)
- 12.5.4 Simens Zika Virus Testing Product Portfolio
- 12.5.5 Simens Recent Developments
- 12.6 Abbott Molecular
- 12.6.1 Abbott Molecular Company Information
- 12.6.2 Abbott Molecular Business Overview
- 12.6.3 Abbott Molecular Revenue in Zika Virus Testing Business (2021-2026)
- 12.6.4 Abbott Molecular Zika Virus Testing Product Portfolio
- 12.6.5 Abbott Molecular Recent Developments
- 12.7 Hologic
- 12.7.1 Hologic Company Information
- 12.7.2 Hologic Business Overview
- 12.7.3 Hologic Revenue in Zika Virus Testing Business (2021-2026)
- 12.7.4 Hologic Zika Virus Testing Product Portfolio
- 12.7.5 Hologic Recent Developments
- 12.8 ELITech Molecular Diagnostics
- 12.8.1 ELITech Molecular Diagnostics Company Information
- 12.8.2 ELITech Molecular Diagnostics Business Overview
- 12.8.3 ELITech Molecular Diagnostics Revenue in Zika Virus Testing Business (2021-2026)
- 12.8.4 ELITech Molecular Diagnostics Zika Virus Testing Product Portfolio
- 12.8.5 ELITech Molecular Diagnostics Recent Developments
- 12.9 EUROIMMUN US
- 12.9.1 EUROIMMUN US Company Information
- 12.9.2 EUROIMMUN US Business Overview
- 12.9.3 EUROIMMUN US Revenue in Zika Virus Testing Business (2021-2026)
- 12.9.4 EUROIMMUN US Zika Virus Testing Product Portfolio
- 12.9.5 EUROIMMUN US Recent Developments
- 12.10 Creative Diagnostics
- 12.10.1 Creative Diagnostics Company Information
- 12.10.2 Creative Diagnostics Business Overview
- 12.10.3 Creative Diagnostics Revenue in Zika Virus Testing Business (2021-2026)
- 12.10.4 Creative Diagnostics Zika Virus Testing Product Portfolio
- 12.10.5 Creative Diagnostics Recent Developments
- 12.11 Vela Diagnostics
- 12.11.1 Vela Diagnostics Company Information
- 12.11.2 Vela Diagnostics Business Overview
- 12.11.3 Vela Diagnostics Revenue in Zika Virus Testing Business (2021-2026)
- 12.11.4 Vela Diagnostics Zika Virus Testing Product Portfolio
- 12.11.5 Vela Diagnostics Recent Developments
- 12.12 InBios International
- 12.12.1 InBios International Company Information
- 12.12.2 InBios International Business Overview
- 12.12.3 InBios International Revenue in Zika Virus Testing Business (2021-2026)
- 12.12.4 InBios International Zika Virus Testing Product Portfolio
- 12.12.5 InBios International Recent Developments
- 12.13 Primerdesign
- 12.13.1 Primerdesign Company Information
- 12.13.2 Primerdesign Business Overview
- 12.13.3 Primerdesign Revenue in Zika Virus Testing Business (2021-2026)
- 12.13.4 Primerdesign Zika Virus Testing Product Portfolio
- 12.13.5 Primerdesign Recent Developments
- 12.14 Altona Diagnostics
- 12.14.1 Altona Diagnostics Company Information
- 12.14.2 Altona Diagnostics Business Overview
- 12.14.3 Altona Diagnostics Revenue in Zika Virus Testing Business (2021-2026)
- 12.14.4 Altona Diagnostics Zika Virus Testing Product Portfolio
- 12.14.5 Altona Diagnostics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst